Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites

Taking stock of the drug industry, from the lab to the medicine chest

February 26, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Scott Olson/Getty Images STAT+ | Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites The announcement comes as the Trump administration is said to be preparing international tariffs on pharmaceuticals. By Lizzy Lawrence STAT+ | A bill is reintroduced in Congress to revise provisions in drug-pricing law "Make no mistake this is yet another attempt by Big Pharma to rig the system in its favor," said Merith Basey of Patients for Affordable Drugs. By Ed Silverman STAT+ | Trump signs order doubling down on making health care prices clearer The president on Tuesday reaffirmed a priority from his first term: making health care prices public. But hospitals have long loathed price transparency. By Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser